These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 1258156

  • 1. [Anticlotting activity of fragment D from fibrinogen and fibrin and its dependence on calcium presence when fragments are obtained from fibrinogen].
    Tolstikh VM, Varets'ka TV.
    Ukr Biokhim Zh; 1976; 48(1):116-21. PubMed ID: 1258156
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of fibrin polymerization by fragment d is affected by calcium, Gly-Pro-Arg and Gly-His-Arg.
    Furlan M, Rupp C, Beck EA.
    Biochim Biophys Acta; 1983 Jan 12; 742(1):25-32. PubMed ID: 6824684
    [Abstract] [Full Text] [Related]

  • 3. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B, Schmutz P, Schmid L, Haeberli A, Lämmle B, Furlan M.
    Thromb Haemost; 1999 Feb 12; 81(2):268-74. PubMed ID: 10064005
    [Abstract] [Full Text] [Related]

  • 4. Quantitation of the inhibitory effect of fibrinogen and its degradation products on fibrin polymerization.
    Belitser VA, Lugovskoy EV, Musjalkovskaja AA, Gogolinskaja GK.
    Thromb Res; 1982 Aug 01; 27(3):261-9. PubMed ID: 6291191
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Inhibition of fibrin assembly by fragment D and its dimer derived from fibrinogen and stabilized fibrin. Evidence for the two-step type of inhibition].
    Platonova TN, Musialkovskaia AA, Tolstykh VM, Belitser VA.
    Biokhimiia; 1980 Oct 01; 45(10):1780-7. PubMed ID: 7236767
    [Abstract] [Full Text] [Related]

  • 8. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
    Dempfle CE, Dollman M, Lill H, Puzzovio D, Dessauer A, Heene DL.
    Blood Coagul Fibrinolysis; 1993 Feb 01; 4(1):79-86. PubMed ID: 8457657
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lymphocyte suppressive peptides from fibrinogen are derived predominantly from the A alpha chain.
    Plow EF, Edgington TS.
    J Immunol; 1986 Sep 15; 137(6):1910-5. PubMed ID: 2943807
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain.
    Furlan M, Stucki B, Steinmann C, Jungo M, Lämmle B.
    Thromb Haemost; 1996 Sep 15; 76(3):377-83. PubMed ID: 8883274
    [Abstract] [Full Text] [Related]

  • 18. The accelerating effect of fibrinogen and early fibrinogen degradation products on erythrocyte sedimentation.
    Marsh NA.
    Thromb Haemost; 1979 Aug 31; 42(2):757-63. PubMed ID: 505378
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Orientation of the carboxy-terminal regions of fibrin gamma chain dimers determined from the crosslinked products formed in mixtures of fibrin, fragment D, and factor XIIIa.
    Siebenlist KR, Meh DA, Wall JS, Hainfeld JF, Mosesson MW.
    Thromb Haemost; 1995 Oct 31; 74(4):1113-9. PubMed ID: 8560422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.